[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pharma Contract Manufacturing Organisations (Cmos) Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

June 2023 | 108 pages | ID: GB043BA55138EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question

A contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Pharma Contract Manufacturing Organisations (Cmos) market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Pharma Contract Manufacturing Organisations (Cmos) market are covered in Chapter 9:
Vetter
Boehringer Ingelheim
Aenova Group
Patheon Inc.
Almac Group
Catalant
AbbVie Inc
CMIC Group
Pharmaceutical Product Development
Lonza AG
Grifols International, S.A
WuXi AppTec
Nectar Lifesciences

In Chapter 5 and Chapter 7.3, based on types, the Pharma Contract Manufacturing Organisations (Cmos) market from 2017 to 2027 is primarily split into:
Injectables
Solid Dosage
Liquid Dosage Forms

In Chapter 6 and Chapter 7.4, based on applications, the Pharma Contract Manufacturing Organisations (Cmos) market from 2017 to 2027 covers:
Pharma company
Biotech company

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa

Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Pharma Contract Manufacturing Organisations (Cmos) market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Pharma Contract Manufacturing Organisations (Cmos) Industry.

2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.

3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MARKET OVERVIEW

1.1 Product Overview and Scope of Pharma Contract Manufacturing Organisations (Cmos) Market
1.2 Pharma Contract Manufacturing Organisations (Cmos) Market Segment by Type
  1.2.1 Global Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Pharma Contract Manufacturing Organisations (Cmos) Market Segment by Application
  1.3.1 Pharma Contract Manufacturing Organisations (Cmos) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Pharma Contract Manufacturing Organisations (Cmos) Market, Region Wise (2017-2027)
  1.4.1 Global Pharma Contract Manufacturing Organisations (Cmos) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2017-2027)
  1.4.3 Europe Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2017-2027)
  1.4.4 China Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2017-2027)
  1.4.5 Japan Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2017-2027)
  1.4.6 India Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2017-2027)
  1.4.8 Latin America Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Market Status and Prospect (2017-2027)
1.5 Global Market Size of Pharma Contract Manufacturing Organisations (Cmos) (2017-2027)
  1.5.1 Global Pharma Contract Manufacturing Organisations (Cmos) Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Pharma Contract Manufacturing Organisations (Cmos) Market

2 INDUSTRY OUTLOOK

2.1 Pharma Contract Manufacturing Organisations (Cmos) Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Pharma Contract Manufacturing Organisations (Cmos) Market Drivers Analysis
2.4 Pharma Contract Manufacturing Organisations (Cmos) Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Pharma Contract Manufacturing Organisations (Cmos) Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Pharma Contract Manufacturing Organisations (Cmos) Industry Development

3 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MARKET LANDSCAPE BY PLAYER

3.1 Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Share by Player (2017-2022)
3.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Market Share by Player (2017-2022)
3.3 Global Pharma Contract Manufacturing Organisations (Cmos) Average Price by Player (2017-2022)
3.4 Global Pharma Contract Manufacturing Organisations (Cmos) Gross Margin by Player (2017-2022)
3.5 Pharma Contract Manufacturing Organisations (Cmos) Market Competitive Situation and Trends
  3.5.1 Pharma Contract Manufacturing Organisations (Cmos) Market Concentration Rate
  3.5.2 Pharma Contract Manufacturing Organisations (Cmos) Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Pharma Contract Manufacturing Organisations (Cmos) Market Under COVID-19
4.5 Europe Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Pharma Contract Manufacturing Organisations (Cmos) Market Under COVID-19
4.6 China Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Pharma Contract Manufacturing Organisations (Cmos) Market Under COVID-19
4.7 Japan Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Pharma Contract Manufacturing Organisations (Cmos) Market Under COVID-19
4.8 India Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Pharma Contract Manufacturing Organisations (Cmos) Market Under COVID-19
4.9 Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Market Under COVID-19
4.10 Latin America Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Pharma Contract Manufacturing Organisations (Cmos) Market Under COVID-19
4.11 Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Market Under COVID-19

5 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Market Share by Type (2017-2022)
5.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Market Share by Type (2017-2022)
5.3 Global Pharma Contract Manufacturing Organisations (Cmos) Price by Type (2017-2022)
5.4 Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue and Growth Rate of Injectables (2017-2022)
  5.4.2 Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue and Growth Rate of Solid Dosage (2017-2022)
  5.4.3 Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue and Growth Rate of Liquid Dosage Forms (2017-2022)

6 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MARKET ANALYSIS BY APPLICATION

6.1 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption and Market Share by Application (2017-2022)
6.2 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption and Growth Rate of Pharma company (2017-2022)
  6.3.2 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption and Growth Rate of Biotech company (2017-2022)

7 GLOBAL PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MARKET FORECAST (2022-2027)

7.1 Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Pharma Contract Manufacturing Organisations (Cmos) Price and Trend Forecast (2022-2027)
7.2 Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Growth Rate of Injectables (2022-2027)
  7.3.2 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Growth Rate of Solid Dosage (2022-2027)
  7.3.3 Global Pharma Contract Manufacturing Organisations (Cmos) Revenue and Growth Rate of Liquid Dosage Forms (2022-2027)
7.4 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Forecast by Application (2022-2027)
  7.4.1 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Value and Growth Rate of Pharma company(2022-2027)
  7.4.2 Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Value and Growth Rate of Biotech company(2022-2027)
7.5 Pharma Contract Manufacturing Organisations (Cmos) Market Forecast Under COVID-19

8 PHARMA CONTRACT MANUFACTURING ORGANISATIONS (CMOS) MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Pharma Contract Manufacturing Organisations (Cmos) Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Pharma Contract Manufacturing Organisations (Cmos) Analysis
8.6 Major Downstream Buyers of Pharma Contract Manufacturing Organisations (Cmos) Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Pharma Contract Manufacturing Organisations (Cmos) Industry

9 PLAYERS PROFILES

9.1 Vetter
  9.1.1 Vetter Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.1.3 Vetter Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Boehringer Ingelheim
  9.2.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.2.3 Boehringer Ingelheim Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Aenova Group
  9.3.1 Aenova Group Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.3.3 Aenova Group Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Patheon Inc.
  9.4.1 Patheon Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.4.3 Patheon Inc. Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Almac Group
  9.5.1 Almac Group Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.5.3 Almac Group Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Catalant
  9.6.1 Catalant Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.6.3 Catalant Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 AbbVie Inc
  9.7.1 AbbVie Inc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.7.3 AbbVie Inc Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 CMIC Group
  9.8.1 CMIC Group Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.8.3 CMIC Group Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Pharmaceutical Product Development
  9.9.1 Pharmaceutical Product Development Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.9.3 Pharmaceutical Product Development Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Lonza AG
  9.10.1 Lonza AG Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.10.3 Lonza AG Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 Grifols International, S.A
  9.11.1 Grifols International, S.A Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.11.3 Grifols International, S.A Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis
9.12 WuXi AppTec
  9.12.1 WuXi AppTec Basic Information, Manufacturing Base, Sales Region and Competitors
  9.12.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.12.3 WuXi AppTec Market Performance (2017-2022)
  9.12.4 Recent Development
  9.12.5 SWOT Analysis
9.13 Nectar Lifesciences
  9.13.1 Nectar Lifesciences Basic Information, Manufacturing Base, Sales Region and Competitors
  9.13.2 Pharma Contract Manufacturing Organisations (Cmos) Product Profiles, Application and Specification
  9.13.3 Nectar Lifesciences Market Performance (2017-2022)
  9.13.4 Recent Development
  9.13.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES

Figure Pharma Contract Manufacturing Organisations (Cmos) Product Picture
Table Global Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume and CAGR (%) Comparison by Type
Table Pharma Contract Manufacturing Organisations (Cmos) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Pharma Contract Manufacturing Organisations (Cmos) Industry Development
Table Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume by Player (2017-2022)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume Share by Player (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume Share by Player in 2021
Table Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD) by Player (2017-2022)
Table Pharma Contract Manufacturing Organisations (Cmos) Revenue Market Share by Player (2017-2022)
Table Pharma Contract Manufacturing Organisations (Cmos) Price by Player (2017-2022)
Table Pharma Contract Manufacturing Organisations (Cmos) Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Region Wise (2017-2022)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume Market Share, Region Wise in 2021
Table Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD), Region Wise (2017-2022)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Revenue Market Share, Region Wise (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue Market Share, Region Wise (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue Market Share, Region Wise in 2021
Table Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume by Type (2017-2022)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume Market Share by Type (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume Market Share by Type in 2021
Table Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD) by Type (2017-2022)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Revenue Market Share by Type (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue Market Share by Type in 2021
Table Pharma Contract Manufacturing Organisations (Cmos) Price by Type (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate of Injectables (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD) and Growth Rate of Injectables (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate of Solid Dosage (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD) and Growth Rate of Solid Dosage (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate of Liquid Dosage Forms (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD) and Growth Rate of Liquid Dosage Forms (2017-2022)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Consumption by Application (2017-2022)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Market Share by Application (2017-2022)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Revenue Market Share by Application (2017-2022)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Consumption and Growth Rate of Pharma company (2017-2022)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Consumption and Growth Rate of Biotech company (2017-2022)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Price and Trend Forecast (2022-2027)
Figure USA Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Market Sales Volume Forecast, by Type
Table Global Pharma Contract Manufacturing Organisations (Cmos) Sales Volume Market Share Forecast, by Type
Table Global Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) Forecast, by Type
Table Global Pharma Contract Manufacturing Organisations (Cmos) Revenue Market Share Forecast, by Type
Table Global Pharma Contract Manufacturing Organisations (Cmos) Price Forecast, by Type
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD) and Growth Rate of Injectables (2022-2027)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD) and Growth Rate of Injectables (2022-2027)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD) and Growth Rate of Solid Dosage (2022-2027)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD) and Growth Rate of Solid Dosage (2022-2027)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD) and Growth Rate of Liquid Dosage Forms (2022-2027)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Revenue (Million USD) and Growth Rate of Liquid Dosage Forms (2022-2027)
Table Global Pharma Contract Manufacturing Organisations (Cmos) Market Consumption Forecast, by Application
Table Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Market Share Forecast, by Application
Table Global Pharma Contract Manufacturing Organisations (Cmos) Market Revenue (Million USD) Forecast, by Application
Table Global Pharma Contract Manufacturing Organisations (Cmos) Revenue Market Share Forecast, by Application
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Value (Million USD) and Growth Rate of Pharma company (2022-2027)
Figure Global Pharma Contract Manufacturing Organisations (Cmos) Consumption Value (Million USD) and Growth Rate of Biotech company (2022-2027)
Figure Pharma Contract Manufacturing Organisations (Cmos) Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Vetter Profile
Table Vetter Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Vetter Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure Vetter Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure Boehringer Ingelheim Revenue (Million USD) Market Share 2017-2022
Table Aenova Group Profile
Table Aenova Group Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Aenova Group Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure Aenova Group Revenue (Million USD) Market Share 2017-2022
Table Patheon Inc. Profile
Table Patheon Inc. Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Patheon Inc. Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure Patheon Inc. Revenue (Million USD) Market Share 2017-2022
Table Almac Group Profile
Table Almac Group Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Almac Group Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure Almac Group Revenue (Million USD) Market Share 2017-2022
Table Catalant Profile
Table Catalant Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Catalant Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure Catalant Revenue (Million USD) Market Share 2017-2022
Table AbbVie Inc Profile
Table AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure AbbVie Inc Revenue (Million USD) Market Share 2017-2022
Table CMIC Group Profile
Table CMIC Group Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CMIC Group Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure CMIC Group Revenue (Million USD) Market Share 2017-2022
Table Pharmaceutical Product Development Profile
Table Pharmaceutical Product Development Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pharmaceutical Product Development Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure Pharmaceutical Product Development Revenue (Million USD) Market Share 2017-2022
Table Lonza AG Profile
Table Lonza AG Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lonza AG Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure Lonza AG Revenue (Million USD) Market Share 2017-2022
Table Grifols International, S.A Profile
Table Grifols International, S.A Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Grifols International, S.A Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure Grifols International, S.A Revenue (Million USD) Market Share 2017-2022
Table WuXi AppTec Profile
Table WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure WuXi AppTec Revenue (Million USD) Market Share 2017-2022
Table Nectar Lifesciences Profile
Table Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) Sales Volume and Growth Rate
Figure Nectar Lifesciences Revenue (Million USD) Market Share 2017-2022




More Publications